• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

iScience . Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection

tetano

Editor, Senior Moderator
iScience


. 2023 Jun 16;26(6):106937.
doi: 10.1016/j.isci.2023.106937. Epub 2023 May 22. Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection

Martina Milighetti[SUP] 1 [/SUP], Yanchun Peng[SUP] 2 3 [/SUP], Cedric Tan[SUP] 4 [/SUP], Michal Mark[SUP] 5 [/SUP], Gayathri Nageswaran[SUP] 1 [/SUP], Suzanne Byrne[SUP] 1 [/SUP], Tahel Ronel[SUP] 1 [/SUP], Tom Peacock[SUP] 1 [/SUP], Andreas Mayer[SUP] 1 [/SUP], Aneesh Chandran[SUP] 1 [/SUP], Joshua Rosenheim[SUP] 1 [/SUP], Matthew Whelan[SUP] 1 [/SUP], Xuan Yao[SUP] 3 [/SUP], Guihai Liu[SUP] 3 [/SUP], Suet Ling Felce[SUP] 3 [/SUP], Tao Dong[SUP] 2 3 [/SUP], Alexander J Mentzer[SUP] 6 [/SUP], Julian C Knight[SUP] 3 6 [/SUP], Francois Balloux[SUP] 4 [/SUP], Erez Greenstein[SUP] 5 [/SUP], Shlomit Reich-Zeliger[SUP] 5 [/SUP], Corinna Pade[SUP] 7 [/SUP], Joseph M Gibbons[SUP] 7 [/SUP], Amanda Semper[SUP] 8 [/SUP], Tim Brooks[SUP] 8 [/SUP], Ashley Otter[SUP] 8 [/SUP], Daniel M Altmann[SUP] 9 [/SUP], Rosemary J Boyton[SUP] 10 11 [/SUP], Mala K Maini[SUP] 1 [/SUP], Aine McKnight[SUP] 7 [/SUP], Charlotte Manisty[SUP] 12 [/SUP], Thomas A Treibel[SUP] 12 [/SUP], James C Moon[SUP] 12 [/SUP]; COVIDsortium Investigators; Mahdad Noursadeghi[SUP] 1 [/SUP], Benny Chain[SUP] 1 [/SUP]



Affiliations
Abstract

T cell responses precede antibody and may provide early control of infection. We analyzed the clonal basis of this rapid response following SARS-COV-2 infection. We applied T cell receptor (TCR) sequencing to define the trajectories of individual T cell clones immediately. In SARS-COV-2 PCR+ individuals, a wave of TCRs strongly but transiently expand, frequently peaking the same week as the first positive PCR test. These expanding TCR CDR3s were enriched for sequences functionally annotated as SARS-COV-2 specific. Epitopes recognized by the expanding TCRs were highly conserved between SARS-COV-2 strains but not with circulating human coronaviruses. Many expanding CDR3s were present at high frequency in pre-pandemic repertoires. Early response TCRs specific for lymphocytic choriomeningitis virus epitopes were also found at high frequency in the preinfection naive repertoire. High-frequency naive precursors may allow the T cell response to respond rapidly during the crucial early phases of acute viral infection.

Keywords: Biological sciences; Cell biology; Immunity; Immunology.

 
Back
Top Bottom